What are the Modified Scarbosa criteria for predicting myocardial ischemia in an adult patient with Left Bundle Branch Block (LBBB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Modified Sgarbossa Criteria for LBBB

The Modified Sgarbossa criteria are a validated electrocardiographic tool for diagnosing acute myocardial infarction in patients with left bundle branch block, replacing the original third criterion (≥5 mm discordant ST elevation) with a proportional measurement (≥1 mm ST elevation with ST/S wave ratio ≤-0.25), which significantly improves sensitivity from 49% to 80% while maintaining 99% specificity. 1

The Three Modified Sgarbossa Criteria

The Modified Sgarbossa criteria consist of three ECG findings, any one of which indicates acute coronary occlusion requiring immediate reperfusion therapy:

1. Concordant ST Elevation

  • ST-segment elevation ≥1 mm in leads with a positive (concordant) QRS complex 2, 3
  • This criterion has 73% sensitivity and 92% specificity 2, 3
  • This represents the most sensitive of the three criteria 2

2. Concordant ST Depression in V1-V3

  • ST-segment depression ≥1 mm in precordial leads V1, V2, or V3 2, 3
  • This criterion has 25% sensitivity but 96% specificity 2, 3
  • Highly specific but less commonly present 2

3. Proportional Discordant ST Elevation (The Modified Component)

  • ST-segment elevation ≥1 mm AND ST/S wave ratio ≤-0.25 1
  • This replaces the original Sgarbossa criterion of ≥5 mm discordant ST elevation 1
  • The modification significantly improves diagnostic accuracy compared to the original weighted criteria (sensitivity 80% vs 49%, P<0.001) 1
  • Specificity remains excellent at 99% 1

Physiologic Rationale

The Modified Sgarbossa criteria work by identifying loss of the normal discordance pattern seen in LBBB:

  • In uncomplicated LBBB, leads with predominantly negative QRS complexes (QS or rS) typically show ST elevation and positive T waves (appropriate discordance) 2
  • Leads with large monophasic R waves normally show ST depression and inverted T waves (appropriate discordance) 2
  • Loss of this normal discordance pattern (concordance) indicates myocardial injury or ischemia 2
  • Real-time validation in patients with intermittent LBBB has confirmed that dynamic ST changes in narrow QRS beats correlate with similar ST changes during LBBB beats 4

Clinical Application and Treatment Algorithm

Immediate Management

Any patient with LBBB meeting any single Modified Sgarbossa criterion should receive immediate reperfusion therapy, preferably primary PCI with door-to-balloon time ≤90 minutes 2, 3:

  • If PCI cannot be performed within 90 minutes of first medical contact AND symptom onset is <3 hours: administer fibrinolytic therapy (Level B recommendation) 3
  • For symptom onset 3-6 hours in high-risk patients: consider fibrinolytic therapy if PCI unavailable within 90 minutes (Level C recommendation) 3

Diagnostic Approach

The American College of Emergency Physicians provides specific guidance:

  • Patients with concordant ST deviations ≥1 mm (0.1 mV) toward the major QRS deflection require immediate reperfusion therapy (Level B) 2
  • Patients with discordant ST deviations meeting the proportional criterion (≥1 mm with ST/S ratio ≤-0.25) in ≥2 contiguous leads require immediate reperfusion therapy 2, 1
  • Serial ECGs should be obtained for patients not meeting criteria but with persistent symptoms to detect evolving ischemia 2, 5

Critical Clinical Considerations

High Specificity, Variable Sensitivity

  • The Modified Sgarbossa criteria have superb specificity (>98%) and positive predictive value for acute coronary occlusion 6, 1
  • Individual criterion sensitivity ranges from 19-80%, meaning absence of criteria does not exclude MI 2, 1
  • The criteria are best used as a "rule-in" test rather than a "rule-out" test 6, 7

Common Pitfalls to Avoid

  • Do not wait for cardiac biomarkers before initiating reperfusion therapy in patients meeting Modified Sgarbossa criteria 3, 6
  • LBBB patients historically receive lower rates of reperfusion therapy despite having higher mortality rates 3
  • The 2013 STEMI guidelines removed "new or presumably new LBBB" as a STEMI equivalent, making the Modified Sgarbossa criteria essential for identifying true acute coronary occlusion 6
  • Measure the ST/S ratio carefully in the modified third criterion—this proportional measurement is what distinguishes it from the original criteria 1

Application Beyond Native LBBB

The Sgarbossa criteria have been validated in ventricular paced rhythms with similar diagnostic characteristics 2:

  • Discordant ST elevation ≥5 mm: 53% sensitivity, 88% specificity 2
  • Concordant ST elevation ≥1 mm: 18% sensitivity, 94% specificity 2
  • ST depression ≥1 mm in V1-V3: 29% sensitivity, 82% specificity 2

Prehospital Recognition

Paramedics can successfully identify acute MI using the Modified Sgarbossa criteria to activate the catheterization laboratory, as demonstrated in case reports of successful early intervention 8

Superiority Over Original Criteria

The validation study comparing Modified to Original Sgarbossa criteria demonstrated:

  • Modified criteria sensitivity: 80% vs Original weighted criteria: 49% (P<0.001) 1
  • Modified criteria sensitivity: 80% vs Original unweighted criteria: 56% (P<0.001) 1
  • Modified criteria specificity: 99% vs Original weighted criteria: 100% (P=0.5, not significant) 1
  • Modified criteria specificity: 99% vs Original unweighted criteria: 94% (P=0.004) 1

The proportional measurement (ST/S ratio ≤-0.25) is superior to the absolute measurement (≥5 mm) because it accounts for the varying amplitude of QRS complexes across different leads and patients 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.